Galapagos announces capital increase
April 21 2017 - 4:03PM
Mechelen, Belgium; 21 April 2017, 22.01 CET;
regulated information - Galapagos NV (Euronext: GLPG; Nasdaq: GLPG)
announces a share capital increase as a result of a public offering
of American Depositary Shares.
In accordance with Belgian transparency
legislation[1], Galapagos notes that its total share capital
currently amounts to €274,854,440.18; the total number of
securities conferring voting rights is 50,815,648, which is also
the total number of voting rights (the "denominator"), and all
securities conferring voting rights and all voting rights are of
the same category. The total number of rights (warrants) to
subscribe to not yet issued securities conferring voting rights is
3,369,337, which equals the total number of voting rights that may
result from the exercise of these warrants. Galapagos does not have
any convertible bonds or shares without voting rights
outstanding.
About Galapagos Galapagos (Euronext & NASDAQ: GLPG)
is a clinical-stage biotechnology company specialized in the
discovery and development of small molecule medicines with novel
modes of action. Our pipeline comprises Phase 3, 2, 1, pre-clinical
and discovery studies in cystic fibrosis, inflammation, fibrosis,
osteoarthritis and other indications. We have discovered and
developed filgotinib: in collaboration with Gilead we aim to bring
this JAK1-selective inhibitor for inflammatory indications to
patients all over the world. Galapagos is focused on the
development and commercialization of novel medicines that will
improve people's lives. The Galapagos group, including
fee-for-service subsidiary Fidelta, has approximately 510
employees, operating from its Mechelen, Belgium headquarters and
facilities in The Netherlands, France, and Croatia.
CONTACT
Investors: |
Media: |
Elizabeth Goodwin |
Evelyn
Fox |
VP IR
& CorporateCommunications+1 781 460 1784 |
Director
Communications +31 6 53 591 999 communications@glpg.com |
Paul van der HorstDirector IR & BusinessDevelopment+31 6 53 725
199 |
|
ir@glpg.com |
|
Forward-looking statementsThis release
may contain forward-looking statements. Such forward-looking
statements are not guarantees of future results. These
forward-looking statements speak only as of the date of publication
of this document. Galapagos expressly disclaims any obligation to
update any forward-looking statements in this document, unless
specifically required by law or regulation.
[1] Belgian Act of 2 May 2007 on the disclosure
of major shareholdings in issuers whose shares are admitted to
trading on a regulated market.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/1aceb031-e307-4569-ad15-3d080a3156ca
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Apr 2023 to Apr 2024